Anti-CD15 抗体 [MEM-158] (ab665)
Key features and details
- Mouse monoclonal [MEM-158] to CD15
- Suitable for: Flow Cyt, IP, ICC/IF
- Reacts with: Species independent
- Isotype: IgM
製品の概要
-
製品名
Anti-CD15 antibody [MEM-158]
CD15 一次抗体 製品一覧 -
製品の詳細
Mouse monoclonal [MEM-158] to CD15 -
由来種
Mouse -
特異性
Human CD15 antigen. -
アプリケーション
適用あり: Flow Cyt, IP, ICC/IFmore details -
種交差性
交差種: Species independent -
免疫原
Tissue/ cell preparation (Human granulocytes).
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle. -
バッファー
pH: 7.40
Preservative: 0.097% Sodium azide
Constituent: PBS -
Concentration information loading... -
精製度
Proprietary Purification -
特記事項（精製）
Purified from TCS. Purified by precipitation and chromatography. Purity >95% by SDS-PAGE. -
ポリ/モノ
モノクローナル -
クローン名
MEM-158 -
アイソタイプ
IgM -
研究分野
関連製品
-
Alternative Versions
-
Compatible Secondaries
-
Conjugation kits
-
Isotype control
アプリケーション
Our Abpromise guarantee covers the use of ab665 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| アプリケーション | Abreviews | 特記事項 |
|---|---|---|
| Flow Cyt | Use at an assay dependent concentration. ab91545 - Mouse monoclonal IgM, is suitable for use as an isotype control with this antibody. |
|
| IP | Use at an assay dependent concentration. | |
| ICC/IF | Use at an assay dependent concentration. |
ターゲット情報
-
関連性
CD15 is a carbohydrate adhesion molecule (and not a protein) that mediates phagocytosis and chemotaxis. Synthesis is directed by FUT4 in lymphoid cells and mature granulocytes, and by FUT9 in promyelocytes and monocytes. -
細胞内局在
Golgi Apparatus; Membrane-bound form in trans cisternae of Golgi. -
別名
- 3 fucosyl N acetyl lactosamine antibody
- 3-FAL antibody
- 3-fucosyl-N-acetyl-lactosamine antibody
see all
参考文献 (1)
ab665 は 1 報の論文で使用されています。
- Kishimoto T. (Eds.) et al. Leucocyte typing VI. Garland Publishing Inc. : (1997). PubMed:
